[1]蒙健林,陈雅璐,王明刚,等.大黄灵仙胶囊治疗胆石症的网络药理学研究[J].西部中医药,2024,37(11):50-55.[doi:10.12174/j.issn.2096-9600.2024.11.12]
　MENG Jianlin,CHEN Yalu,WANG Minggang,et al.Network Pharmacology-based Study of Daihuang Lingxian Capsules in the Treatment of Cholelithiasis[J].Western Journal of Traditional Chinese Medicine,2024,37(11):50-55.[doi:10.12174/j.issn.2096-9600.2024.11.12]
点击复制

大黄灵仙胶囊治疗胆石症的网络药理学研究

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
37
期数:
2024年11期
页码:
50-55
栏目:
二次研究
出版日期:
2024-11-15

文章信息/Info

Title:
Network Pharmacology-based Study of Daihuang Lingxian Capsules in the Treatment of Cholelithiasis
作者:
蒙健林1, 陈雅璐2, 王明刚2, 王兵2, 胡嗣钦2, 王清坚2
1.广西中医药大学，广西 南宁 530023
2.广西中医药大学第一附属医院，广西 南宁 530023
Author(s):
MENG Jianlin1, CHEN Yalu2, WANG Minggang2, WANG Bing2, HU Siqin2, WANG Qingjian2
1.Guangxi University of Chinese Medicine, Nanning 530023, China
2.The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning 530023, China
关键词:
大黄灵仙胶囊; 网络药理学; 胆石症; 靶点; 信号通路
Keywords:
capsules; network pharmacology; cholelithiasis; targets; signaling pathway
分类号:
R575.6
DOI:
10.12174/j.issn.2096-9600.2024.11.12
文献标志码:
A
摘要:
目的通过网络药理学方法分析大黄灵仙胶囊治疗胆石症的作用机制。 方法使用中药系统药理分析平台提取大黄灵仙胶囊的有效活性成分及对应作用靶点，结合UniProt数据库对靶点进行标准化。通过GeneCards数据库检索得到胆石症相关靶点，借助R语言筛选大黄灵仙胶囊与胆石症的交集靶点，借助Perl语言映射出交集靶点对应的有效活性成分，构建药物治疗疾病的“有效活性成分-靶点”数据库，利用Cytoscape软件对数据库绘制可视化图并筛选出核心有效成分；借助STRING数据库对交集靶点进行蛋白相互作用分析，DAVID数据库对交集靶点进行基因本体论（gene ontology，GO）功能富集分析和京都基因与基因组百科全书（kyoto encyclopedia of genes and genomes，KEGG）通路富集分析。 结果得到160个大黄灵仙胶囊有效活性成分，116个对应作用靶点，其中与胆石症的共同靶点28个。大黄灵仙胶囊治疗胆石症的核心成分有槲皮素、β-谷甾醇、山柰酚、异鼠李素等，治疗的主要核心靶点有白细胞介素6、血管内皮生长因子A、表皮生长因子受体等，主要通过细胞增殖调控、一氧化氮生物合成过程调控等生物作用在细胞核浆、内吞体膜、胞外间隙等细胞位置，发挥类固醇结合、酶结合、转录因子结合等分子功能参与调控癌变通路、缺氧诱导因子1（hypoxia inducible factor-1，HIF-1）信号通路等，发挥治疗胆石症的效用。 结论网络药理学构建了大黄灵仙胶囊治疗胆石症多活性成分、多基因靶点、多治疗通路相互作用的特点，筛选出大黄灵仙胶囊作用于胆石症的基因靶点和信号通路，为进一步探索大黄灵仙胶囊治疗胆石症的作用机制提供参考依据。
Abstract:
ObjectiveTo analyze the mechanism of Daihuang (radix et rhizoma rhei) Lingxian capsules in the treatment of cholelithiasis based on network pharmacology. MethodsTraditional Chinese medicine systems pharmacology database and analysis platform (TCMSP) was applied to extract the active ingredients and the corresponding targets of action of the medicine, the standardization of the targets were conducted by combining with Uniprot database; cholelithiasis-related targets were searched from GeneCards database; the intersecting targets between the medicine and cholelithiasis were searched via R language, and the active ingredients corres-ponding with the intersecting targets were mapped out via Perl language, to construct the database of "active ingredients-targets" for the treatment of disease with the medicine, Cytoscape software was utilized to visualize the database and screen the core active ingredients; STRING database was applied to analyze protein-protein interaction (PPI) of the intersecting targets, DAVID database was used to perform GO and KEGG enrichment analysis of the intersecting targets. ResultsThe study has yielded 160 active ingredients of the medicine, 116 corresponding targets, and 28 targets shared with the disease. The core ingredients of the medicine for the treat-ment of cholelithiasis contained quercetin, β-Sitosterol, kaempferol and isorhamnetin, and the main core targets of the treatment were IL-6, VEGFA and EGFR, these ingredients participated in the regulation of the oncogenic pathway, hypoxia inducible factor-1 (HIF-1) signaling pathway by developing steroid-binding, enzyme-binding, transcription factor-binding and other molecular functions, mainly through the regulation of cell proliferation, nitric oxide biosynthesis process and other biological effects in the cell nucleus plasma, endosomal membrane, extracellular space and other cells, thus treating cholelithiasis. ConclusionNetwork pharmacology has constructed the characteristics of multi-active components, multi-genetic targets and multi-therapeutic pathways of the capsules in the treatment of cholelithiasis, and screened out the genetic targets and signaling pathways of the medicine acting on cholelithiasis, which could produce the references for further exploration into the mechanism of the medicine in the treatment of cholelithiasis.

相似文献/References:

[1]刘新宇,陈星宇,毕鸿昊,等.基于网络药理学和分子对接探讨枸杞子-菟丝子-当归治疗视网膜色素变性的作用机制[J].西部中医药,2025,38(12):79.[doi:10.12174/j.issn.2096-9600.2025.12.16]
　LIU Xinyu,CHEN Xingyu,BI Honghao,et al.Exploring the Mechanism of Action of Gouqizi-Tusizi-Angelica in the Treatment of Retinitis Pigmentosa Based on Network Pharmacology and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2025,38(11):79.[doi:10.12174/j.issn.2096-9600.2025.12.16]
[2]赵靖昌,丛超,吴盼晴,等.基于网络药理学和分子对接技术探讨开郁种玉汤治疗非器质性女性不孕症的机制[J].西部中医药,2026,39(01):45.[doi:10.12174/j.issn.2096-9600.2026.01.10]
　ZHAO Jingchang,CONG Chao,WU Panqing,et al.Mechanism of Qi Stagnation-relieving Offspring-generating Decoction in the Treatment of Non-organic Female Infertility: Network Pharmacology and Molecular Docking Technology[J].Western Journal of Traditional Chinese Medicine,2026,39(11):45.[doi:10.12174/j.issn.2096-9600.2026.01.10]
[3]杨雅婷,李宝玲,徐春悦,等.归脾汤基于肠道菌群治疗血管性痴呆的网络药理学研究[J].西部中医药,2026,39(01):79.[doi:10.12174/j.issn.2096-9600.2026.01.15]
　YANG Yating,LI Baoling,XU Chunyue,et al.Network Pharmacology-based Study on Guipi Decoction in Treating Vascular Dementia Based on Gut Microbiota[J].Western Journal of Traditional Chinese Medicine,2026,39(11):79.[doi:10.12174/j.issn.2096-9600.2026.01.15]
[4]田颢颐,田耘.基于网络药理学方法探讨活血药治疗IgA肾病的作用机制[J].西部中医药,2026,39(01):87.[doi:10.12174/j.issn.2096-9600.2026.01.16]
　TIAN Haoyi,TIAN Yun.Network Pharmacology-based Exploration into the Mechanism of Blood-activating Drugs in the Treatment of IgA Nephropathy[J].Western Journal of Traditional Chinese Medicine,2026,39(11):87.[doi:10.12174/j.issn.2096-9600.2026.01.16]
[5]李晓彤,李家立,曹志群,等.基于网络药理学和分子对接技术探讨参苓白术散治疗功能性腹泻的作用机制[J].西部中医药,2026,39(01):96.[doi:10.12174/j.issn.2096-9600.2026.01.17]
　LI Xiaotong,LI Jiali,CAO Zhiqun,et al.Mechanism of Shenling Baizhu Powder in Treating Functional Diarrhea Based on Network Pharmacology and Molecular Docking Technology[J].Western Journal of Traditional Chinese Medicine,2026,39(11):96.[doi:10.12174/j.issn.2096-9600.2026.01.17]
[6]王嘉宁,王健.基于数据挖掘和网络药理学方法探讨惊恐障碍的中药治疗机制[J].西部中医药,2026,39(01):107.[doi:10.12174/j.issn.2096-9600.2026.01.18]
　WANG Jia?ning,WANG Jian.Mechanism of TCM Treatment for Panic Disorder Based on Data Mining and Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2026,39(11):107.[doi:10.12174/j.issn.2096-9600.2026.01.18]
[7]偶勇,古娜,晁旭.基于网络药理学探讨黄芪-莪术治疗肝癌的作用机制[J].西部中医药,2026,39(01):129.[doi:10.12174/j.issn.2096-9600.2026.01.21]
　OU Yong,GU Na,CHAO Xu.Network Pharmacology-based Exploration into the Mechanism of Huangqi-Ezhu in Treating Liver Cancer[J].Western Journal of Traditional Chinese Medicine,2026,39(11):129.[doi:10.12174/j.issn.2096-9600.2026.01.21]
[8]韩燕鸿,李君,潘建科,等.基于网络药理学方法探讨丹参-牡丹皮配伍治疗膝骨性关节炎的作用机制[J].西部中医药,2026,39(01):65.[doi:10.12174/j.issn.2096-9600.2026.01.13]
　HAN Yanhong,LI Jun,PAN Jianke,et al.Network Pharmacology-based Discussion on the Mechanism of Danshen-Mudanpi Combination in Treating Knee Osteoarthritis[J].Western Journal of Traditional Chinese Medicine,2026,39(11):65.[doi:10.12174/j.issn.2096-9600.2026.01.13]
[9]黄小芮,刘建华,闫占峰,等.基于网络药理学与分子对接探讨苓桂术甘汤治疗良性阵发性位置性眩晕的机制[J].西部中医药,2026,39(03):108.[doi:10.12174/j.issn.2096-9600.2026.03.21]
　HUANG Xiaorui,LIU Jianhua,YAN Zhanfeng,et al.Network Pharmacology and Molecular Docking Based Exploration into the Mechanism of Lingguizhugan Decoction in the Treatment of Benign Paroxysmal Positional Vertigo[J].Western Journal of Traditional Chinese Medicine,2026,39(11):108.[doi:10.12174/j.issn.2096-9600.2026.03.21]
[10]王雪莹,李潇然,赵进喜,等.网络药理学与分子对接法探究鬼箭羽-牛蒡子药对治疗糖尿病肾病的机制[J].西部中医药,2026,39(03):115.[doi:10.12174/j.issn.2096-9600.2026.03.22]
　WANG Xueying,LI Xiaoran,ZHAO Jinxi,et al.Investigating the Mechanism of Guijianyu - Niubangzi Herb Pair Against Diabetic Kidney Disease Using Network Pharmacology and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2026,39(11):115.[doi:10.12174/j.issn.2096-9600.2026.03.22]

备注/Memo

备注/Memo:
蒙健林（1996—），女，硕士学位，助教。研究方向：中西医结合临床与基础研究。国家自然科学基金（82060867，82474507）；广西自然科学基金重点项目（2024GXNSFDA010025）；广西名中医传承工作室建设项目（GZY2024011）。
更新日期/Last Update: 2024-11-15